“[L]egalization in Colorado is associated with an increase of nearly 51,000 hotel rooms rented per month [and] once commercial sale is permitted, there is an increase of almost 120,000 room rentals per month.”
Category: SCIENCE
NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules
“We believe that the adoption of these rules may further stonewall efforts to advance our scientific understanding of cannabis by unduly expanding the DEA’s authority and control over decisions that ought to be left up to health experts and scientists.”
Study: Far Fewer Incidences of Vaping Illness Reported in States with Legal Cannabis Markets
“Just like alcohol prohibition gave rise to the illicit production of dangerous ‘bathtub gin,’ marijuana prohibition provides bad actors, not licensed businesses, the opportunity to fulfill consumers’ demand – sometimes with tragic results.”
Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent
“Claims about the benefits of using CBD on viral infections were largely supported by CBD online retailers and most often appear to be a biased interpretation of the scientific literature or a dishonest manipulation of the information for commercial purposes.”
NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”
“These new rules are unduly onerous, expensive, and impractical. Even if they are ultimately implemented, it is unlikely that they would greatly facilitate clinical cannabis research in the United States.”
Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects
Authors reported that patients administered oral THC experienced a “nine-fold greater reduction in opioid consumption” compared to controls.
Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain
The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine.
Study: Adult-Use Cannabis Access Associated with Decreased Sales of OTC Sleep Aids
Researchers reported: “For the first time, we show a statistically significant negative association between recreational access to cannabis and OTC sleep aid sales.”
Study Finds “Little Support” for Cannabis Impacting Cognitive Abilities
The occasional use of cannabis during late adolescence is not independently associated with adverse effects on cognitive abilities in young adulthood, according to longitudinal data published in the journal Drug and Alcohol Dependence. A team of investigators affiliated with the University of Colorado at Boulder assessed the impact of cannabis use on cognition, executive function, and working memory in 856 individual twins. Cannabis consumers were compared to their non-using twins in late adolescence and then again in their early twenties. Most of the cannabis consuming participants in the study reported occasional use of the substance, but not daily use. Authors found “little support for a causal effect of cannabis use on cognition. This conclusion is consistent with those from previous…
Study: Daily Cannabis Use Among Pain Patients Associated with Less Non-Prescription Opioid Use
Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.” Specifically, subjects who consumed cannabis daily “had about 50 percent lower odds of using illicit opioids every day [as] compared to cannabis non-users.”